NY-ESO-1的克
[Abstract]:Objective: cancer is a disease with the fastest increasing morbidity and mortality in the world. It is a promising way to study and treat cancer from the immunological point of view, which is a great threat to human health and life. Finding and studying new and effective tumor antigens is the core of this approach. In recent years, it has been found that CT antigen is highly tissue restricted expression and has immunogenicity in tumor patients, which can induce humoral immunity and cellular immunity, which provides a new opportunity for tumor immunotherapy. NY-ESO-1 is the most immunogenicity molecule. Based on the molecular biological and immunological experiments, the tumor specific antigen (NY-ESO-1) gene was cloned, the expression vector was constructed and the whole NY-ESO-1 protein was highly expressed in Escherichia coli. The expression of NY-ESO-1 in different types of tumor tissues was studied, which laid a foundation for the further study of the mechanism of NY-ESO-1 expression and its application in tumor diagnosis and immunotherapy. Methods: the full length of human NY-ESO-1 gene was obtained from A375 cells by RT-PCR method. The recombinant expression plasmid was constructed. The NY-ESO-1 protein was induced by IPTG and purified by affinity chromatography. The polyclonal antibody was obtained by immunizing animals with the purified GST fusion protein. The expression profiles of NY-ESO-1 and other CT antigens in tumor tissues were used to observe the relationship between NY-ESO-1 and tumorigenesis and development, and the significance of preparation of multivalent vaccine against CT antigen was analyzed. Results: the NY-ESO-1 gene was cloned successfully, and the recombinant expression plasmid pGEX-4T-2 / NY-ESO-1 was constructed. The prokaryotic expression conditions of GST-NY-ESO-1 protein were optimized successfully, and the highly expressed NY-ESO-1 protein was obtained. A inducing surface with molecular weight consistent with the theoretical value was observed by SDS-PAGE analysis.
【學位授予單位】:中國人民解放軍軍事醫(yī)學科學院
【學位級別】:碩士
【學位授予年份】:2005
【分類號】:R392
【共引文獻】
相關(guān)期刊論文 前10條
1 林思祖;曹光球;丁國昌;劉寶;;杉木葉片蛋白質(zhì)提取方法的改良[J];安徽農(nóng)學通報(上半月刊);2009年17期
2 崔林開;葉華智;;3種ELISA法檢測Bt殺蟲蛋白的比較研究[J];安徽農(nóng)業(yè)科學;2005年11期
3 王自良;張海棠;王艷榮;張改平;;氯霉素人工免疫原的合成與鑒定[J];安徽農(nóng)業(yè)科學;2006年09期
4 張麗霞;張國強;;大蒜蛋白酶抑制劑的分離純化與部分性質(zhì)研究[J];安徽農(nóng)業(yè)科學;2006年18期
5 孫新城;司艷紅;張莉;王云龍;;抗煙草青枯病拮抗菌的篩選及抑菌活性研究[J];安徽農(nóng)業(yè)科學;2008年14期
6 張曉晴;蔡宇杰;廖祥儒;張大兵;;香樟(Cinnamomum camphora)果實酪氨酸酶的分離純化及特性分析[J];安徽農(nóng)業(yè)科學;2008年15期
7 柏玉潔;朱啟忠;陳晚華;王旭;任延剛;;毛栓菌木聚糖酶的純化[J];安徽農(nóng)業(yè)科學;2008年19期
8 彌春霞;孫豐賓;李金龍;張妍;曹振嶺;;東北小油菜葉蛋白提取工藝的研究[J];安徽農(nóng)業(yè)科學;2008年20期
9 謝焱;顧國賢;李崎;;重組β-1,3-1,4-葡聚糖酶的純化及部分酶學性質(zhì)研究[J];安徽農(nóng)業(yè)科學;2008年20期
10 張靠穩(wěn);馬愛瑛;葉東平;楊婧;;DFRKN-1堿性磷酸酶的提取純化和主要理化性質(zhì)研究[J];安徽農(nóng)業(yè)科學;2008年26期
相關(guān)會議論文 前10條
1 王在貴;何瑞國;錢世鈞;劉朝良;;特異腐質(zhì)霉纖維素酶的酶譜分析[A];現(xiàn)代農(nóng)業(yè)理論與實踐——安徽現(xiàn)代農(nóng)業(yè)博士科技論壇論文集[C];2007年
2 張新妙;馬潤宇;;用膜結(jié)晶技術(shù)制備蛋白質(zhì)晶體的研究[A];第二屆全國膜分離技術(shù)在食品工業(yè)中應(yīng)用研討會論文集[C];2006年
3 高娟;唐明森;王艷玲;蔣再學;竺薇;羅滿林;;重組豬α干擾素發(fā)酵工藝的研究[A];中國畜牧獸醫(yī)學會獸醫(yī)公共衛(wèi)生學分會第三次學術(shù)研討會論文集[C];2012年
4 鄧利玲;胡小芳;盧明s,
本文編號:2173604
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2173604.html